BA
BSTG

Bard Associates’s Biostage, Inc. Common Stock BSTG Stock Holding History

Bard Associates’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-15,552
Closed -$49K – 174
2014
Q4 		$49K Sell
15,552
-1,000
-6% -$4.95K 0.02% 168
2014
Q3 		$134K Sell
16,552
-450
-3% -$3.68K 0.06% 156
2014
Q2 		$178K Sell
17,002
-1,775
-9% -$15.1K 0.07% 175
2014
Q1 		$170K Sell
18,777
-23,155
-55% -$137K 0.07% 172
2013
Q4 		$198K Buy
+41,932
New +$196K 0.08% 171

Other funds holding BSTG

State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bard Associates's BSTG Position: Q1 2015 in Review

Bard Associates sold out of Biostage, Inc. Common Stock (BSTG) in Q1 2015, closing a stake of 15,552 shares — an estimated $49K sold.

Bard Associates first reported a position in BSTG in Q4 2013 and held it in 5 quarters. The position peaked at $198K in Q4 2013. 37 funds tracked by Wall St. Rank hold BSTG as of Q1 2015.

  • Bard Associates reported no remaining Biostage, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Bard Associates sold 15,552 Biostage, Inc. Common Stock shares in Q1 2015, an estimated $49K.
  • Bard Associates first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 5 quarters.
  • Bard Associates's Biostage, Inc. Common Stock position peaked at $198K in Q4 2013.
  • 37 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q1 2015.

Based on Bard Associates's 13F filing for Q1 2015, filed 15 May 2015.